Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0000950170-25-061898
Filing Date
2025-05-01
Accepted
2025-05-01 16:30:23
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B5 srzn_424b5_20250501.htm 424B5 289013
2 GRAPHIC img250065577_0.jpg GRAPHIC 29766
  Complete submission text file 0000950170-25-061898.txt   331331
Mailing Address 171 OYSTER POINT BLVD SUITE 400 SOUTH SAN FRANCISCO CA 94080
Business Address 171 OYSTER POINT BLVD SUITE 400 SOUTH SAN FRANCISCO CA 94080 650-475-2820
Surrozen, Inc./DE (Filer) CIK: 0001824893 (see all company filings)

EIN.: 301374889 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-286703 | Film No.: 25903733
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)